Stay updated on Durvalumab + Tremelumab in LS-SCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.

Latest updates to the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check14 days agoChange DetectedAdded a new site revision entry (v3.4.3) and removed the previous revision entry (v3.4.2) in the page's version history.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedRevision: v3.4.2 was added, and the Notice about government funding and the prior Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check50 days agoChange DetectedAdded a site-wide notice about government funding and NIH Clinical Center operating status. Updated the history page to Revision: v3.4.1 and removed the v3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check57 days agoChange DetectedRecord History page now includes a glossary toggle and color-coded highlights to distinguish additions and deletions, along with updated revision notes (v3.4.0). Capitalization for 'No FEAR Act Data' has been standardized.SummaryDifference0.6%

- Check71 days agoChange DetectedThe page history now shows an added Revision: v3.3.4 and a removed Revision: v3.3.3, reflecting a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Durvalumab + Tremelumab in LS-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.